Status:
UNKNOWN
Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache
Lead Sponsor:
Association pour la Recherche au Centre d'Urgence des Céphalées
Conditions:
Chronic Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic headache is most often associated with drug abuse and medication overuse headache (MOH) is the main complication of migraine disease results in chronic daily headache. The first phase of treat...
Eligibility Criteria
Inclusion
- Migrainous according to the criteria of the International Headache Society
- Medication-overuse headaches according of the International Headache Society
- No prophylaxis treatment or same prophylaxis treatment from more than one month
- Signed informed consent
Exclusion
- Pregnancy
- One or more failed withdrawal treatment
- analgesic treatment for another reason than headache
- Contraindication of normobaric oxygen therapy
- Contraindication of ketoprofen (rescue therapy)
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02302027
Start Date
December 1 2014
End Date
October 1 2016
Last Update
January 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Urgence des Céphalées, hôpital Lariboisière
Paris, France, 75010